Compare 10X Genomics Inc (TXG) vs Vistra Corp (VST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Vistra Corp — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Vistra Corp trades at $162.33 (market cap $53.27B). The key difference: Vistra Corp is far larger — about 9.7× 10X Genomics Inc's market cap, and Vistra Corp pays a 0.58% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | VST | |
|---|---|---|
Market Cap | $5.48B | $53.27B |
Sector | Health | Technology |
52-Week High | $45.80 | $217.92 |
52-Week Low | $11.34 | $134.71 |
Enterprise Value | $5.02B | $75.03B |
Dividend Yield | — | 0.58% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →
